Special edition on diabetic retinopathy

Authors

  • Dr.Nyenze E.M. Department of Ophthalmology University of Nairobi, Kenyatta National Hospital

DOI:

https://doi.org/10.64666/joecsa.2017.210

Abstract

Welcome readers to this special edition of JOECSA on the
management of diabetic retinopathy. With the increase of
the prevalence of non-communicable diseases in the region,
more and more people are currently being diagnosed
with diabetes mellitus. These people carry a lifetime risk
of developing Diabetic Retinopathy (DR). When not
diagnosed early and properly managed, these people end
up developing preventable severe visual impairment or
blindness. The use of anti-Vascular Endothelial Growth
Factors (anti-VEGF) in the management of DR has
totally changed its management in the recent past. New
guidelines continue to be developed in line with the new
discoveries

Downloads

Published

2017-12-01

How to Cite

M.Nyenze, E. (2017). Special edition on diabetic retinopathy. Journal of Ophthalmology of Eastern, Central and Southern Africa (JOECSA), 21(02). https://doi.org/10.64666/joecsa.2017.210

Issue

Vol. 21 No. 02 (2017): Volume 21, Number 02, December 2017- Journal of Ophthalmology of Eastern Central and Southern Africa

Section

Editorials

Categories

License

Copyright (c) 2026 Dr.Nyenze E.M.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

JOECSA publishes all content Open Access under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Authors retain copyright. Anyone may share and adapt the work for any purpose, provided appropriate credit is given to the original author(s) and the source. License: https://creativecommons.org/licenses/by/4.0/